Evaxion Biotech AS (EVAX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $25.27M
Last updated: Nov 17, 2026 at 4:10 PM ET
Evaxion Biotech AS (EVAX) Stock Chart
Evaxion Biotech AS (EVAX) has a latest price of $2.78 on Nov 17, 2026, 59.8% below its 52-week high of $6.92. Its price fell 49.1% over the past 12 months. The month-end price fell 99.2% over the 5 years through Oct 2026, a compound annual decline of 62.2%.
Price Chart
From Feb 2021 to Oct 2026, its highest month-end close was $482.00 in Sep 2021 and its lowest $1.53 in Apr 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart EVAX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for EVAX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 11.7%, and over 6 months it fell 30.2%. The month-end price fell 94.8% over the 3 years through Oct 2026, a compound annual decline of 62.6%.
| Period | Change |
|---|---|
| 1 month | -16.5% |
| 3 months | -11.7% |
| 6 months | -30.2% |
| 12 months | -49.1% |
| 12 months, with dividends | -49.1% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -94.8% | -62.6% |
| 5 years | -99.2% | -62.2% |
Price by Year
Its best calendar year was 2025, when the price rose 12.8%, and its weakest was 2024, when it fell 87.7%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $2.93 | -38.6% |
| 2025 | $4.77 | +12.8% |
| 2024 | $4.23 | -87.7% |
| 2023 | $34.28 | -61.4% |
| 2022 | $88.75 | -59.8% |
Trading Range
The price is 10.6% below its 50-day average of $3.11 and 19.1% below its 200-day average of $3.43.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $2.78 | |
| 52-week high | $6.92 | -59.8% |
| 52-week low | $2.65 | +4.9% |
| 50-day average | $3.11 | -10.6% |
| 200-day average | $3.43 | -19.1% |
Price Risk
Over 3 years, its largest fall from a peak was 97.6%.
| Measure | Value |
|---|---|
| 1-year beta | 0.45 |
| Largest fall, 1 year | -58.7% |
| Largest fall, 3 years | -97.6% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About EVAX
What is EVAX's 1-year price change?
Evaxion Biotech AS's price fell 49.1% over the past 12 months. With dividends included, the 12-month total return was -49.1%.
What is EVAX's 5-year price change?
Evaxion Biotech AS's month-end price fell 99.2% over the 5 years through Oct 2026, a compound annual decline of 62.2%. These figures leave out dividends.
What is EVAX's 52-week high and low?
Evaxion Biotech AS's 52-week high is $6.92 and its 52-week low is $2.65. Its latest price of $2.78 on Nov 17, 2026 is 59.8% below the high.
What is EVAX's beta?
Evaxion Biotech AS's 1-year beta against the S&P 500 is 0.45, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 58.7%.
Is the EVAX chart free?
Yes. Advanced Charting for EVAX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
EVAX pages: Overview, Charting, Earnings, Forecast, Statistics, Valuation, Competitors